Myeloma Paper of the Day, June 3rd, suggested by Robert Orlowski
Robert Orlowski shared on X:
“Myeloma Paper of the Day: Comparison of infectious complications with BCMA-directed therapies in multiple myeloma finds greater risk with bispecifics vs. CAR T’s, and higher risk in the setting of low IgG and ANC levels.”
Source: Robert Orlowski/X
Comparison of infectious complications with BCMA-directed therapies in multiple myeloma
Authors: Karthik Nath, Tala Shekarkhand, David Nemirovsky, Andriy Derkach, Bruno Almeida Costa, Noriko Nishimura, Tasmin Farzana, Colin Rueda, David Chung, Heather Landau, Oscar Lahoud, Michael Scordo, Gunjan Shah, Hani Hassoun, Kylee Maclachlan, Neha Korde, Urvi Shah, Carlyn Rose Tan, Malin Hultcrantz, Sergio Giralt, Saad Usmani, Zainab Shahid, Sham Mailankody, and Alexander Lesokhin.
Other posts featuring Robert Orlowski on OncoDaily.
Robert Orlowski holds multiple positions at The University of Texas MD Anderson Cancer Center, including Chairman, Ad Interim Director of Myeloma, and Professor of Medicine in the Departments of Lymphoma/Myeloma and Experimental Therapeutics within the Division of Cancer Medicine.
Additionally, he chairs the SWOG Barlogie/Salmon Myeloma Committee, which is part of the National Clinical Trials Network, dedicated to advancing new therapies and understanding the biology of myeloma.
